Clinical applications of neuroimaging in patients with Alzheimer’s disease: a review from the Fourth Canadian Consensus Conference on the Diagnosis and Treatment of Dementia 2012
Open accessAbstract
In May 2012, the Fourth Canadian Consensus Conference on the Diagnosis and Treatment of Dementia brought together in Montreal experts from around Canada to update Canadian recommendations for the diagnosis and management of patients with neurodegenerative conditions associated with deterioration of cognition. Multiple topics were discussed. The present paper is a highly condensed version of those recommendations that were produced to support discussions in the field of neuroimaging for clinical diagnosis of those conditions.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Major consensus dementia investigation guidelines all recommend structural brain imaging as part of the investigation of bvFTD.
“Major consensus dementia investigation guidelines all recommend structural brain imaging as part of the investigation of bvFTD (Knopman et al. , 2001; Filippi et al. , 2012; Soucy et al. , 2013).”
From Recommendations to distinguish behavioural variant frontotemporal dementia from psychiatric disorders (2020) · cites this paper as Soucy et al. , 2013
The CCCDTD4 recommendations (Table 1; page unavailable) say structural imaging is indicated for most people with cognitive impairment, but not required for all. The “Structural neuroimaging in memory clinics” section says MRI is preferred for detecting atrophy patterns in fronto-temporal dementias. The paper therefore supports imaging as relevant to investigating these dementias, but does not establish that all major consensus guidelines recommend it specifically for bvFTD. (LLM, conf=0.85)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
The citation lists haven’t been fetched yet
References 110 · Cited by 25
Research works printed but not linked: 2
- 2012 Canadian Consensus conference on Dementia http://www.cccdtd.ca
- Rowe C Pejoska S Mulligan RS Jones G Chan G Svensson S Cselényi Z Masters C Villemagne V Head-to-head comparison of 11C-PIB and 18F-AZD4694 for beta-amyloid imaging in aging and dementia [abstract O1-04-04] Alzheimer's Association International Conference Abstracts; July 14-19 2012; Vancouver, Canada23828739
- Authors
- Soucy, J.-P., Bartha, R., Bocti, C., Borrie, M., Burhan, A. M., Laforce, R., & Rosa-Neto, P.
- Affiliations
- Montreal Neurological Institute and Hospital (CA)
- Western University (CA)
- Centre Hospitalier Universitaire de Sherbrooke (CA)
- Centre hospitalier universitaire de Québec (CA)
- Corresponding author
- Soucy, Jean-Paul
- Venue
- Alzheimer's Research & Therapy
- Published
- 2013-07
- Volume
- 5
- Issue
- S1
- Pages
- S3-S3
- ISSN
- 1758-9193 (ISSN-L)
- PMC
- PMC3980588
- OpenAlex
- W2128967643
- Semantic Scholar
- d023b02f03f8208495bb9f99504181761ec00e30
- Cited by
- 25
- References
- 110
- Citations by year
- 2026: 1 · 2025: 2 · 2022: 1 · 2021: 2 · 2020: 3 · 2018: 2 · 2017: 6 · 2016: 3 · 2015: 2 · 2014: 1 · 2013: 2
- FWCI
- 1.90
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Alzheimer s Research & Therapy (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Alzheimer's Association
- Canadian Institutes of Health Research
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Medical Imaging Techniques and Applications
- Keywords
- Alzheimer's disease, neuroimaging, dementia diagnosis, clinical guidelines, neurodegenerative diseases, cognitive decline
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
